Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02107170Phase 4Completed
Phase 4 trial of sevoflurane in aortic aneurysm and arteriosclerosis obliterans (2 arms). Primary endpoint: Number of patients with postoperative cognitive dysfunction at 7 days. Started Feb 2014; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02107170.